Hear how malnutrition affects people with cancer in different ways, even impacting cancer treatment plans.
Myeloproliferative neoplasms (MPNs), while rare, are blood cancers that carry a significant symptom burden and can develop aggressively. Hear why community practices need to monitor symptoms carefully and about a new tool that can help assess symptoms more accurately and help care teams form treatment plans. In this episode, CANCER BUZZ speaks with Srdan Verstovsek, MD, PhD, United Energy Resources Inc. professor of Medicine and hematologist oncologist at MD Anderson Cancer Center, University of Texas and Julie Huynh-Lu, PA-C and physician assistant in the Department of Leukemia at MD Anderson Cancer Center, about MPNs and the integration of the MPN10 questionnaire into the electronic health record (EHR).
Guests
Julie Huynh-Lu, PA-C
Physician Assistant, Department of Leukemia, Division of Cancer Medicine
MD Anderson Cancer Center, University of Texas
Houston, TX
Srdan Verstovsek, MD, PhD
Professor of Medicine, Department of Leukemia, Division of Cancer Medicine
Hematologist Oncologist
MD Anderson Cancer Center, University of Texas
Houston, TX
“As we recognize that quality of life is one of the major factors that we are to correct, we need to have an objective way of measuring how bad the quality of life is. We now have a full-fledged questionnaire, the MPN-10, which has ten questions that identify the ten most common problems that patients with myelofibrosis suffer from– which is very useful information for us to see what we are facing when we see the patients, [identify] the time to treat, and whether the treatment is helping.” — Srdan Verstovsek, MD, PhD
This is the first video podcast in a four-episode series on MPNs in connection with the education program “Advancing Care for Patients with Myeloproliferative Neoplasms (MPNs).”
Resources:
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Cancer Care Centers.
July 8, 2026
June 30, 2026
At the 2026 ASCO Annual Meeting, the Louisiana Oncology Society received the ASCO Jeffrey C Ward Affiliate Advocacy Award for advancing critical advocacy priorities that have translated into meaningful legislative victories. The Iowa Oncology Society and Washington State Medical Oncology Society were also recognized for their advocacy efforts in 2025 at the meeting, receiving second place awards.
